Robert V. Lapenta Jr. - Director, Therapeuticsmd, Inc

As of June 24, 2019


Robert V. Lapenta Jr. Net Worth

  • Net worth is estimated to be at least $46.03M
  • Owns at least 10,000 units of Therapeuticsmd, Inc stock

Robert V. Lapenta Jr. Compensation at Therapeuticsmd, Inc in 2020

  • Earned a $600,000 salary
  • Rewarded $1,524,751 in stock value and options
  • Received a total compensation of $2,746,536

Robert V. Lapenta Jr. Trading

  • Largest purchase of shares was 5,000 units , worth over $18.32K on May 13, 2014
  • In total has made about 9 transactions over 7 years
  • Usually trades in June and May, with the busiest year in 2015 and 2014
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Robert V. Lapenta Jr. Mailing Address

  • Mailing address is C/o Aston Capital 177 Broad St., 12th Floor Stamford CT 06901 CT

Therapeuticsmd, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Robert G. Finizio 2020 $600,000 $1,524,751 - $600,000 $21,785 $2,746,536
Robert G. Finizio 2019 $600,000 - $2 $600,000 $22,218 $1,222,220
John C.K. Milligan, IV 2020 $450,000 $1,479,105 - $315,000 $31,285 $2,275,390
John C.K. Milligan, IV 2019 $450,000 - $645,956 $315,000 $29,683 $1,440,639
Edward Borkowski 2020 $430,000 - $3,599,967 $365,500 $81,687 $4,477,154
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/25743/000119312521116458/d152560ddef14a.htm

Therapeuticsmd, Inc Insider Trading

  • The most recent transaction was 33,445 units bought on August 19, 2021 by Karen Ling worth over $25.08K
  • In the last 8 years, insiders at Therapeuticsmd, Inc sold an estimated value of $50.3M and bought an estimated value of $4.23M
  • The most active traders are John C.K. Milligan IV, Secretary/CEO subsidiary,  Robert G Finizio, CEO,  and Tommy G Thompson, Director
  • Insider trading is most common in August, with the busiest year in 2018

TherapeuticsMD, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1